Loading…
Hemp Access and Consumer Safety Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Hemp Access and Consumer Safety Act This bill allows hemp and hemp-derived ingredients to be included in food and dietary supplements. Current law prohibits, with limited exceptions, the sale of food and dietary supplements that contain an ingredient that is an active ingredient in (1) an approved drug, or (2) a drug for which there have been substantial and publicly known clinical investigations. This bill exempts hemp and hemp-derived ingredients, such as hemp-derived cannabidiol, from this prohibition. The Food and Drug Administration may establish labeling and packaging requirements for such foods and dietary supplements.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (16)
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2022 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $160,270 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
- General interest in ACA legislative/regulatory changes. - General interest in the Hemp Access and Consumer Safety Act (S. 1698). - Support for HR 6134, CBD Product Safety and Standardization Act.
Client expense: $700,000 · Firm income: Not reported
Government targets: Treasury, Dept of
2022 · fourth_quarter · Agriculture
H.R.841, S.1698, H.R.6645, H.R.6134 USDA Final Rule on Hemp, Growing Climate Solutions Act, SAFE banking Act, National Defense Authorization Act, other hemp regulatory matters
Client expense: Not reported · Firm income: $80,000
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · fourth_quarter · Government Issues
HR 820 - Climb Act; all provisions of the bill HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill HR 6134 - CBD Product Safety and Standardization Act of 2021; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Agriculture
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
| Republican |
| KY |
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022 S.4591, the Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
S.4348, FDASLA Act of 2022, Mandatory product registration Monitor the following: Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4090, Dietary Supplement Listing Act of 2022, Entirety H.R.7667, Food and Drug Amendments of 2022, Entirety Regulatory enforcement of dietary supplements, Mandatory product registration issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety Cosmetics Regulatory Reform related issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $178,500 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
- General interest in ACA legislative/regulatory changes. - General interest in the Hemp Access and Consumer Safety Act (S. 1698). - Support for HR 6134, CBD Product Safety and Standardization Act.
Client expense: $680,000 · Firm income: Not reported
Government targets: Treasury, Dept of
2022 · third_quarter · Agriculture
H.R.841, S.1698, H.R.6645, H.R.6134 USDA Final Rule on Hemp, Growing Climate Solutions Act, SAFE banking Act, National Defense Authorization Act, other hemp regulatory matters
Client expense: Not reported · Firm income: $80,000
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · third_quarter · Consumer Issues/Safety/Products
Issues related to cannabis legalization, production, and regulation; H.R. 3617-The Marijuana Opportunity Reinvestment and Expungement Act; H.R. 841 - The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S.1698 - Hemp Access and Consumer Safety Act
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4348, FDASLA Act of 2022, Mandatory product registration S.4090, Dietary Supplement Listing Act of 2022, Entirety H.R.7667, Food and Drug Amendments of 2022, Entirety Monitor the following: Over-the-counter dietary supplement products as qualified medical expenses under HSA/FSA's Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.5214, To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements, HSA/FSA supplement related issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety S.2100, Personal Care Products Safety Act, Generally H.R.5747/S.1654, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, generally
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill HR 8200 - Climb Act; all provisions of the bill HR 6134 - CBD Product Safety and Standardization Act of 2021; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill S 4591 - Cannabis Administration and Opportunity Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $142,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Agriculture
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022 S.4591, the Cannabis Administration and Opportunity Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill HR 6134 - CBD Product Safety and Standardization Act of 2021; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698 the Hemp Access and Consumer Safety Act S. 4090 Dietary Supplement Listing Act of 2022 S. 4348 the Food and Drug Administration Safety and Landmark Advancements Act of 2022
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Agriculture
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
Issues related to cannabis legalization, production, and regulation; H.R. 3617-The Marijuana Opportunity Reinvestment and Expungement Act; H.R. 841 - The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S.1698 - Hemp Access and Consumer Safety Act
Client expense: $140,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Health Issues
- General interest in ACA legislative/regulatory changes. - General interest in the Hemp Access and Consumer Safety Act (S. 1698). - Support for HR 6134, CBD Product Safety and Standardization Act.
Client expense: $700,000 · Firm income: Not reported
Government targets: Treasury, Dept of
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Regulatory enforcement of dietary supplements, Mandatory product registration issues Food Safety regulation related issues S.4348, FDASLA Act of 2022, Mandatory product registration S.4090, Dietary Supplement Listing Act of 2022, Entirety Monitor the following: Over-the-counter dietary supplement products as qualified medical expenses under HSA/FSA's Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.5214, To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements, HSA/FSA supplement related issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety S.2100, Personal Care Products Safety Act, Generally H.R.5747/S.1654, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, generally H.R.7667, Food and Drug Amendments of 2022, Entirety
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2022 · second_quarter · Consumer Issues/Safety/Products
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022. SHOP SAFE Act H.R. 3429/S.1843. INFORM Consumers Act S. 936. America Competes Act of 2022, H.R. 4521.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products. S.4090, Dietary Supplement Listing Act. S. 4348, FDASLA Act of 2022.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Client expense: $160,270 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Agriculture
H.R. 841, S. 1698, USDA Final Rule on Hemp, Growing Climate Solutions Act, SAFE banking Act, National Defense Authorization Act, other hemp regulatory matters
Client expense: Not reported · Firm income: $80,000
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · first_quarter · Food Industry (safety, labeling, etc.)
H.R. 6134 CBD Product Safety and Standardization Act Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act
Client expense: $372,777 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Agriculture
Impact on agricultural interests of FDA's lack of clarity on CBD/hemp dietary supplement products (S. 1698/ H.R. 841).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES
2022 · first_quarter · Consumer Issues/Safety/Products
Issues related to cannabis legalization, production, and regulation; H.R. 3617-The Marijuana Opportunity Reinvestment and Expungement Act; H.R. 841 - The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S.1698 - Hemp Access and Consumer Safety Act
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Agriculture
H.R. 841, S. 1698, USDA Final Rule on Hemp, Growing Climate Solutions Act, SAFE banking Act, National Defense Authorization Act, other hemp regulatory matters
Client expense: Not reported · Firm income: $80,000
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2022 · second_quarter · Food Industry (safety, labeling, etc.)
H.R 6134 CBD Product Safety and Standardization Act Food Modernization Act, P.L. 11-353 Notifications for Food Contact Substances Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act
Client expense: $372,777 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
- General interest in ACA legislative/regulatory changes. - General interest in the Hemp Access and Consumer Safety Act (S. 1698). - Support for HR 6134, CBD Product Safety and Standardization Act.
Client expense: $700,000 · Firm income: Not reported
Government targets: Treasury, Dept of
2022 · first_quarter · Food Industry (safety, labeling, etc.)
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Improvments to the Dietary Supplement regulatory structure, no bill number S.1698 - Hemp Access and Consumer Safety Act
Client expense: $156,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Food Industry (safety, labeling, etc.)
Regulatory enforcement of dietary supplements, Mandatory product registration issues Monitor the following: Over-the-counter dietary supplement products as qualified medical expenses under HSA/FSA's Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.5214, To amend the Internal Revenue Code of 1986 to permit expenditures from health savings accounts, flexible spending arrangements, and health reimbursement arrangements for dietary supplements, HSA/FSA supplement related issues Hemp-Derived Cannabidiol (CBD) regulations H.R.841, Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021, generally S.1698, Hemp Access and Consumer Safety Act, Entirety S.2100, Personal Care Products Safety Act, Generally H.R.5747/S.1654, A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products as qualified medical expenses, generally
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698, the Hemp Access and Consumer Safety Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Health Issues
Issues relating to the approval of cannabinoids in supplements and food. H.R. 841: Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021. S1698: Hemp Access and Consumer Safety Act.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · third_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act Cannabis Administration and Opportunity Act (Discussion Draft)
Client expense: $268,959 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Food Industry (safety, labeling, etc.)
H.R.1202/S.578 Food Allergy Safety, Treatment, Education, and Research Act (FASTER Act) Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act
Client expense: $518,508 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
HR 841 Issues related to regulation of dietary supplements S.1698, the Hemp Access and Consumer Safety Act
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Health Issues
- General interest in ACA legislative/regulatory changes. - General interest in the Hemp Access and Consumer Safety Act (S. 1698).
Client expense: $700,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Alcohol & Tobacco Tax & Trade Bureau (TTB), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. International Trade Commission (ITC), White House Office
2021 · fourth_quarter · Consumer Issues/Safety/Products
Policy initiatives related to the development of a mandatory product listing system of dietary supplement and functional food product labels & information. Policy initiatives on hemp-derived cannabidiol (CBD), supporting actions that will lead to a legal and regulatory pathway to market for hemp-derived CBD products, pertaining to dietary supplements. H.R. 3699 - The Toxic Free Food Act of 2021; to direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to update and clarify its rule on substances generally recognized as safe, and for other purposes. H.R. 2668 - Consumer Protection and Recovery Act H.R. 841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020. S. 1698 - Hemp Access and Consumer Safety Act (S.) - To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all hemp-derived cannabidiol-related provisions. S. 1843/H.R. 3429 - SHOP SAFE Act of 2021 S. 936 - INFORM Consumers Act H.R. 5502 - To require online marketplaces to verify certain information regarding high-volume third party sellers of consumer products on such online marketplaces and to disclose to consumers certain contact and other information regarding such high-volume third party sellers. H.R. 3699 - Toxic Free Food Act of 2021 H.R. 2668 - Consumer Protection and Recovery Act
Client expense: $60,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Budget/Appropriations
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Food Industry (safety, labeling, etc.)
Regulation of dietary supplements and natural products. Specifically related to mandatory product listing and increased authority for FDA to combat illegal supplements. S. 1698 and H.R. 841 to provide for regulation of CBD products.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Consumer Issues/Safety/Products
Issues related to cannabis legalization, production, and regulation; H.R. 3617-The Marijuana Opportunity Reinvestment and Expungement Act; H.R. 841 - The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; S.1698 - Hemp Access and Consumer Safety Act
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R. 6134 CBD Product Safety and Standardization Act Food Safety Modernization Act, P.L.111-353 Notifications for Food Contact Substances H.R. 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 Hemp Access and Consumer Safety Act
Client expense: $380,824 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Surface Transportation Board (STB), Transportation, Dept of (DOT), White House Office
2021 · fourth_quarter · Health Issues
Issues relating to the approval of cannabinoids in supplements and food. H.R. 841: Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021. S1698: Hemp Access and Consumer Safety Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Government Issues
HR 841 Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021; all provisions of the bill HR 3617 MORE Act; To decriminalize and deschedule cannabis, to provide for reinvestment in certain persons adversely impacted by the War on Drugs, to provide for expungement of certain cannabis offenses, and for other purposes; all provisions of the bill HR 1996/ S 910 SAFE Act, Secure And Fair Enforcement Banking Act of 2019, to create protections for depository institutions that provide financial services to cannabis-related legitimate businesses and service providers for such businesses, and for other purposes; all provisions of the bill S 1698 Hemp Access and Consumer Safety Act; all provisions of the bill
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE